Expression of mutant alpha-synuclein modulates microglial phenotype in vitro

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Reactive microglia and alpha-synuclein (α-synuclein) protein deposits are hallmarks of Parkinson's disease (PD).
• Microglial inflammation is implicated in PD pathogenesis, with mutations in α-synuclein linked to familial PD.
• Prior studies indicate α-synuclein regulates microglial phenotype, prompting investigation into mutant forms' role in PD-associated microgliosis.

Purpose of the Study:

• To investigate how wild type and mutant α-synuclein expression affects microglial cell phenotype.
• To determine if α-synuclein overexpression influences inflammatory markers, phagocytic capacity, and neurotoxicity in microglia.

Main Methods:

• Murine microglial cell line (BV2) was transiently transfected with human wild type (WT), A30P, and A53T mutant α-synuclein.
• Assessed microglial phenotype changes using Western blot, ELISA, phagocytosis assays, and neurotoxicity assays.

Main Results:

• Overexpression of α-synuclein induced a reactive microglial phenotype, increasing cyclooxygenase-2 (Cox-2) levels.
• Transfected cells showed elevated secretion of pro-inflammatory cytokines (TNF-α, IL-6) and nitric oxide production.
• Phagocytic ability was impaired, evidenced by decreased lysosomal-associated membrane protein 1 (LAMP-1) levels, but neurotoxicity did not increase.

Conclusions:

• Overexpression of α-synuclein induces a reactive microglial phenotype characterized by increased inflammatory mediator secretion and impaired phagocytosis.
• These findings highlight a potential mechanism by which α-synuclein contributes to neuroinflammation in Parkinson's disease.